Pfizer Inc. Revs Up For Testing Of Over-The-Counter Lipitor

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in the Wall Street Journal that the company has started a clinical study to support the application for low-dose atorvastatin (10 mg). Over-the-counter statins have been unsuccessfully proposed in the past. Merck tried several times to gain approval for lovastatin (Mevacor).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC